Ozempic is not marketed as a weight loss drug and is prescribed to those with type 2 diabetes to help manage their condition ...

“There is some evidence that there is altered brain activity related to reward-related behaviors, including appetite and ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

Dementia is the UK's biggest killer, claiming more lives than heart attacks and strokes combined. Despite exhaustive research ...

I am concerned the mad scramble to get hold of weight-loss jabs has led to a Wild West market, where it's easy to buy these ...

The study supports prior research that found the same thing.

Heavy drinkers have an increased risk of developing brain lesions associated with memory and thinking problems, a new study ...

A recent survey reveals the foods that people are less likely to eat once they start taking GLP-1 medications like Ozempic.

Board-certified rheumatologist Dr. Mahsa Tehrani discusses President Donald Trump’s possible 25% tariff on overseas ...

GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

Drugs originally developed to treat type 2 diabetes, particularly GLP-1 receptor agonists such as semaglutide (sold as ...